search
Back to results

The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions

Primary Purpose

Post-operative Complications, Surgical Site Infection, Surgical Wound Infection

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Prevena™ Incision Management System (PIMS)
Standard-of-care Dressing
Sponsored by
3M
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Post-operative Complications focused on measuring surgical site infection, nosocomial infection, post-operative complication, surgical incision risk, surgical incision infection, negative pressure wound therapy, wound management, cesarean section surgery, wound dehiscence, wound infection, surgical closure, wound disruption, subcutaneous approximation, wound separation, seroma, hematoma, subcutaneous closure, obesity, cesarean, incision, massive obesity, obese, pregnancy, cesarean delivery, superobesity, wound complication

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

The Subject:

  1. is a female aged ≥ 18 years
  2. is able to provide her own informed consent
  3. will undergo a Cesarean section procedure using a subcuticular skin closure technique within the next 42 days
  4. will require a surgical incision able to be covered completely by the PIMS skin interface
  5. has a BMI ≥ 35 kg/m2 as determined during the Screening Period up to 42 days pre-surgery
  6. is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:

    1. Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital, or uninfected urinary tract is not entered

      - OR -

    2. Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital, or uninfected urinary tract are entered under controlled conditions and without unusual contamination
  7. is willing and able to return for all scheduled and required study visits
  8. is not concurrently enrolled in another clinical intervention trial which may impact maternal health or the surgical site

Exclusion Criteria:

The Subject:

  1. is ASA Class P4, P5, or P6 (Appendix F - American Society of Anesthesiologists (ASA) Physical Status Classification System)
  2. has a systemic bacterial or fungal infection at the time of surgery
  3. has a remote-site skin infection at the time of surgery
  4. has a life expectancy of < 12 months
  5. is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:

    1. Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract

      - OR -

    2. Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
  6. experiences intraoperative hemorrhage requiring transfusion, disseminated-intravascular coagulopathy (DIC) or other medical or surgical condition during the Cesarean section deemed by the investigator to pose a prohibitively high risk for surgical re-exploration
  7. who, in the investigator's opinion, would have any clinically significant condition that would impair the participant's ability to comply with the study procedures
  8. has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives

Sites / Locations

  • Duke University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Standard Dressing

Prevena™ (PIMS)

Arm Description

Standard-of-care includes coverage of the sutured incision with sterile gauze and non-penetrable barrier (e.g., Tegaderm™) consistent with the national standard for dressing Cesarean section incisions.

PIMS unit is a single patient use, battery-powered, disposable unit that can provide continuous -125 mmHg negative pressure over a 7-day therapy period.

Outcomes

Primary Outcome Measures

Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery.
Incidence of postoperative surgical site occurrences (SSOs) post Cesarean section surgery. SSOs include: Unanticipated local inflammatory response Prolonged drainage Fluid collection Dehiscence Surgical site infection (SSI)

Secondary Outcome Measures

Incidence Rate of Surgical Incision Intervention (SII) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery.
Incidence rate of surgical incision intervention (SII) post Cesarean section surgery. Interventions include: Antimicrobials for surgical site infection Surgical drainage of the incision Surgical incision packing Adjunctive negative pressure therapy Debridement Re-operation

Full Information

First Posted
October 10, 2011
Last Updated
July 29, 2022
Sponsor
3M
search

1. Study Identification

Unique Protocol Identification Number
NCT01450631
Brief Title
The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions
Official Title
A Prospective, Randomized, Evaluation of the Prevena™ Incision Management System on Closed Incisions in Obese Subjects Undergoing Cesarean Section Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
February 2012 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
3M

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to compare the post-surgical standard-of-care dressing to the Prevena™ Incision Management System in women undergoing Cesarean section surgery.
Detailed Description
This is a randomized, open-label, single-center, Phase IV, comparative interventional study looking at the effect of the Prevena™ Incision Management System (PIMS) on Cesarean section Subjects compared to a control arm treated with a standard-of-care surgical incision dressing. The prospective, post-marketing clinical study described in this protocol will assess the effectiveness and functional performance of PIMS on closed incisions. Clinical outcomes of interest for this study are defined as Surgical Site Occurrences (SSOs) that include unanticipated local inflammatory response, prolonged drainage, fluid collection, dehiscence, and surgical site infection (SSI). This investigation will compare these outcomes to a control group consisting of Subjects screened for the same inclusion and exclusion criteria but treated with a standard-of-care surgical incision dressing.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post-operative Complications, Surgical Site Infection, Surgical Wound Infection
Keywords
surgical site infection, nosocomial infection, post-operative complication, surgical incision risk, surgical incision infection, negative pressure wound therapy, wound management, cesarean section surgery, wound dehiscence, wound infection, surgical closure, wound disruption, subcutaneous approximation, wound separation, seroma, hematoma, subcutaneous closure, obesity, cesarean, incision, massive obesity, obese, pregnancy, cesarean delivery, superobesity, wound complication

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
92 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard Dressing
Arm Type
Active Comparator
Arm Description
Standard-of-care includes coverage of the sutured incision with sterile gauze and non-penetrable barrier (e.g., Tegaderm™) consistent with the national standard for dressing Cesarean section incisions.
Arm Title
Prevena™ (PIMS)
Arm Type
Experimental
Arm Description
PIMS unit is a single patient use, battery-powered, disposable unit that can provide continuous -125 mmHg negative pressure over a 7-day therapy period.
Intervention Type
Device
Intervention Name(s)
Prevena™ Incision Management System (PIMS)
Other Intervention Name(s)
PIMS, NPWT, Negative Pressure Wound Therapy
Intervention Description
PIMS is a non-significant-risk, FDA Class II, medical device commercially available in the USA, Canada and Europe. The prospective, post-marketing clinical study described in this protocol will assess the effectiveness and functional performance of the system. The PIMS unit is a single patient use, battery-powered, disposable unit that can provide continuous -125 mmHg negative pressure over a 7-day therapy period. It is an easy to use device that also provides audible and visual alerts for low battery, maximum canister volume, and leak conditions. Additional alerts include system error and device life-cycle expiration (8 days). It is contained in a water-resistant housing, which allows the Subject to lightly shower with the device. Wound fluids are contained within the 45 mL canister.
Intervention Type
Device
Intervention Name(s)
Standard-of-care Dressing
Other Intervention Name(s)
Standard Dressing
Intervention Description
The standard-of-care is consistent with the national standard for dressing Cesarean section incisions and includes, but not limited to, coverage of the sutured incision with sterile gauze and non-penetrable barrier (e.g., Tegaderm™). The non-penetrable barrier may be left in place for a minimum of 1 day and no longer than 2 days (± 4 hours) to promote epithelialization of the surgical incision edges. After the dressing is removed, the surgical site is left exposed to air to promote further healing. Other therapies include traditional gauze dressings with or without advanced therapies such as hydrocolloids, growth factors, and Negative Pressure Wound Therapy.
Primary Outcome Measure Information:
Title
Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery.
Description
Incidence of postoperative surgical site occurrences (SSOs) post Cesarean section surgery. SSOs include: Unanticipated local inflammatory response Prolonged drainage Fluid collection Dehiscence Surgical site infection (SSI)
Time Frame
Post-op Day 42 (+/- 10 days) after Cesarean section surgery
Secondary Outcome Measure Information:
Title
Incidence Rate of Surgical Incision Intervention (SII) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery.
Description
Incidence rate of surgical incision intervention (SII) post Cesarean section surgery. Interventions include: Antimicrobials for surgical site infection Surgical drainage of the incision Surgical incision packing Adjunctive negative pressure therapy Debridement Re-operation
Time Frame
Post-op Day: 42 (+/- 10 days) after Cesarean section surgery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The Subject: is a female aged ≥ 18 years is able to provide her own informed consent will undergo a Cesarean section procedure using a subcuticular skin closure technique within the next 42 days will require a surgical incision able to be covered completely by the PIMS skin interface has a BMI ≥ 35 kg/m2 as determined during the Screening Period up to 42 days pre-surgery is preoperatively assessed to undergo a procedure with a CDC Wound Classification of: Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital, or uninfected urinary tract is not entered - OR - Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital, or uninfected urinary tract are entered under controlled conditions and without unusual contamination is willing and able to return for all scheduled and required study visits is not concurrently enrolled in another clinical intervention trial which may impact maternal health or the surgical site Exclusion Criteria: The Subject: is ASA Class P4, P5, or P6 (Appendix F - American Society of Anesthesiologists (ASA) Physical Status Classification System) has a systemic bacterial or fungal infection at the time of surgery has a remote-site skin infection at the time of surgery has a life expectancy of < 12 months is preoperatively assessed to undergo a procedure with a CDC Wound Classification of: Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract - OR - Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera experiences intraoperative hemorrhage requiring transfusion, disseminated-intravascular coagulopathy (DIC) or other medical or surgical condition during the Cesarean section deemed by the investigator to pose a prohibitively high risk for surgical re-exploration who, in the investigator's opinion, would have any clinically significant condition that would impair the participant's ability to comply with the study procedures has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert Heine, MD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University Medical Center
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27705
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions

We'll reach out to this number within 24 hrs